Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 619-599-0 | CAS number: 915095-94-2
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August - October 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (OECD 423) and in compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- not specified
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- (3S)-3-{4-[(2-chloro-5-iodophenyl)methyl]phenoxy}oxolane
- EC Number:
- 619-599-0
- Cas Number:
- 915095-94-2
- Molecular formula:
- C17 H16 Cl I O2
- IUPAC Name:
- (3S)-3-{4-[(2-chloro-5-iodophenyl)methyl]phenoxy}oxolane
- Reference substance name:
- (S)-3-[4-(2-Chloro-5-iodobenzyl) phenoxy] tetrahydrofuran
- Cas Number:
- 915095-94-2
- Molecular formula:
- C17 H16 Cl I O2
- IUPAC Name:
- (S)-3-[4-(2-Chloro-5-iodobenzyl) phenoxy] tetrahydrofuran
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 0,5% hydroxyethylcellulose (HEC) in deionized water
- Doses:
- 300mg/kg and 2000mg/kg
- No. of animals per sex per dose:
- 300mg/kg : 3 male and 3 female; starting dose
2000mg/kg : 3 male and 3 female - Control animals:
- no
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 - <= 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed in any of the animals at 300 or 2000mg/kg.
- Clinical signs:
- other: No clinical signs were observed in the animals at 300 or 2000mg/kg.
- Gross pathology:
- No visible lesions were observed in any of the animals at 300 or 2000 mg/kg at terminal necropsy.
Applicant's summary and conclusion
- Interpretation of results:
- Category 5 based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- According to the GHS system, IN00078283 adminstered orally at dose levels of 300 and 2000 mg/kg body weight in male and female rats was considered to be a Category 5 test substance with an LD50 greater than 2000-5000 mg/kg.
- Executive summary:
No mortality was observed in animals at 300 or 2000 mg/kg. No clinical signs were observed in the animals at 300 or 2000 mg/kg. All animals at 300 and 2000 mg/kg gained weight throughout the study. No visible lesions in any of the animals at 300 or 2000 mg/kg at terminal necropsy.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
